Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 43, Issue 2 (Apr 2005)

Issues

Interferences in coagulation tests – evaluation of the 570-nm method on the Dade Behring BCS analyser

Ralf Junker
  • Institute of Arteriosclerosis Research, University of Münster, Münster, Germany and Institute of Clinical Chemistry and Laboratory Medicine, University of Münster, Münster, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Margit Käse / Helmut Schulte / Ruth Bäumer / Claus Langer / Ulrike Nowak-Göttl
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2005.041

Abstract

The Dade Behring BCS is a coagulation analyser with optical reaction detection (standard 405nm). The present study was conducted to evaluate measurement at 570nm for analyses in interfering plasma samples. Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer in normal (n=50), lipaemic (n=60), icteric (n=113), and haemolytic (n=58) samples were measured at 405 and 570nm. As they are unaffected by the optical properties of the sample, the mechanical STAcompact analyser (Roche Diagnostics) and an ELISA technique were defined as the “comparison” methods. The percentage of valid PT results using the 570-nm method varied from 54% (lipaemic samples) to 97% (haemolytic samples). Valid aPTT measurements were found in 67% (lipaemic samples) up to 93% (icteric samples) of samples. Fibrinogen measurement revealed valid results in 58% (lipaemic samples) to 100% (haemolytic samples) of samples. The number of valid D-dimer results varied from 28% (lipaemic material) up to 100% (haemolytic material). Significant inter-method differences were found: aPTT in lipaemic (BCS 405 vs. 570nm) and icteric samples (STAcompact vs. BCS 405 and 570nm); fibrinogen in lipaemic (BCS 405 vs. 570nm), icteric (BCS 405 vs. 570nm; STAcompact vs. BCS 570nm) and haemolytic samples (STAcompact vs. BCS 405 and 570nm). Differences between the BCS 570-nm and the STAcompact methods were in most cases low and less pronounced than between the BCS 570- and 405-nm methods, making the BCS 570-nm method an alternative to measurement at 405nm. Limitations have to be taken into account regarding lipaemic plasma.

Keywords: coagulation analyser; interference; method evaluation; optical detection

References

  • 1

    The International Federation of Clinical Chemistry. IFCC provisional recommendation on quality control in clinical chemistry. J Clin Chem Biochem 1976;14:270–9. Google Scholar

  • 2

    Guder WG, da Fonseca-Wollheim F, Heil W, Schmitt YM, Töpfer G, Wisser H, Zawta B. The haemolytic, icteric and lipaemic sample – recommendations regarding their recognition and prevention of clinically relevant interferences. J Lab Med 2000; 24: 357–64. Google Scholar

  • 3

    Selby C. Interference in immunoassay. Ann Clin Biochem 1999; 36: 704–21. CrossrefGoogle Scholar

  • 4

    Berends F, Engelhardt W, Fickenscher K, Junker R, Keller F, Meyers W, et al. Multicentre evaluation of a new coagulation analyzer for coagulometric, chromogenic and immunologic tests [abstract]. Ann Hematol 1997;74(Suppl II). Google Scholar

  • 5

    Grafmeyer D, Bondon M, Manchon M, Levillain P. The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Eur J Clin Chem Clin Biochem 1995; 33: 31–52. Google Scholar

  • 6

    BCS Coagulation System – Instruction Manual – Version 2.2. Marburg, Germany: Dade Behring, 2000. Google Scholar

  • 7

    STAcompact – User Manual – Version 1.0b. Mannheim, Germany: Roche Diagnostics, 1996. Google Scholar

  • 8

    Lammers M, Gressner AM. Immunonephelometric quantification of free haemoglobin. J Clin Chem Clin Biochem 1987; 25: 363–7. Google Scholar

  • 9

    Dempfle CE, Zips S, Ergul H, Heene DL, Fibrin Assay Comparative Trial Study Group. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT Study Group. Thromb Haemost 2001; 85: 671–8. Google Scholar

  • 10

    Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 1031–3. Google Scholar

  • 11

    Oosting JD, Hoffmann JJ. Evaluation of an automated photometric fibrinogen assay. Blood Coagul Fibrinolysis 1997; 8: 321–6. CrossrefGoogle Scholar

  • 12

    Ermens AA, Bury JG, Wijn-Maas EC. Evaluation of an automated hemostasis testing analyzer, the Thrombolyzer Combi. Clin Lab 2000; 46: 463–7. Google Scholar

  • 13

    Quehenberger P, Kapiotis S, Handler S, Ruzicka K, Speiser W. Evaluation of the automated coagulation analyzer Sysmex CA 6000. Thromb Res 1999; 96: 65–71. CrossrefGoogle Scholar

About the article

Both authors contributed equally to this work; Corresponding author: Ralf Junker, MD, Abendrothsweg 31, 20251 Hamburg, Germany Phone: +49-40-46090175, Fax: +49-40-46093045,


Received: 2004-07-02

Accepted: 2004-12-14

Published Online: 2011-09-21

Published in Print: 2005-04-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.041.

Export Citation

©2005 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Katie Moynihan, Kerry Johnson, Lahn Straney, Christian Stocker, Ben Anderson, Prem Venugopal, and John Roy
Perfusion, 2017, Page 026765911772049
[2]
Rachid Essalmani, Delia Susan-Resiga, Johann Guillemot, Woojin Kim, Vatsal Sachan, Zuhier Awan, Ann Chamberland, Marie-Claude Asselin, Kévin Ly, Roxane Desjardins, Robert Day, Annik Prat, and Nabil G. Seidah
Journal of Biological Chemistry, 2017, Volume 292, Number 25, Page 10564
[3]
Núria Segarra, Joan Huguet, and Beatriz Fernández-Forner
Blood Coagulation & Fibrinolysis, 2017, Volume 28, Number 1, Page 112
[4]
Trung Nguyen, Matthew Musick, and Jun Teruya
Pediatric Critical Care Medicine, 2014, Volume 15, Number 2, Page 178
[5]
Anna Liveris, Ricardo A. Bello, Patricia Friedmann, Melissa A. Duffy, Deepa Manwani, James S. Killinger, Daniel Rodriquez, and Samuel Weinstein
Pediatric Critical Care Medicine, 2014, Volume 15, Number 2, Page e72
[6]
Giuseppe Lippi, Paola Avanzini, Valentina Zobbi, and Luigi Ippolito
Blood Coagulation & Fibrinolysis, 2012, Volume 23, Number 5, Page 461
[7]
Xiaojie Zhang and Bing Bai
Journal of Nanjing Medical University, 2008, Volume 22, Number 3, Page 193
[8]
M. E. Bauman, Mark Belletrutti, M. L. Bauman, and M. P. Massicotte
Pediatric Critical Care Medicine, 2012, Volume 13, Number 1, Page 1
[9]
Bing Bai, Douglas J Christie, Robert T Gorman, and Jogin R Wu
Blood Coagulation & Fibrinolysis, 2008, Volume 19, Number 6, Page 569

Comments (0)

Please log in or register to comment.
Log in